Delivery Order SPE2DB25D3201-SPE2DB25FNWNE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of September 29, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $11,087.70 delivery order to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with performance to be completed by September 23, 2025. This competitively awarded, firm fixed-price contract is being executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $5,543.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 mg vials of Padcev on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitive award, with no set-aside designation, is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the agency. This award is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials. This competitively awarded, firm fixed price contract was executed on September 2, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical distributor will perform the delivery at its corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's continued...
- AmerisourceBergen Drug Corp was awarded a $27.7K delivery order by the Defense Logistics Agency's Medical Supply Chain to supply 30 mg vials of Padcev, a specialized oncology medication. The contract, executed on September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price, non-set-aside competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of PADCEV 30 mg vials, a specialized pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $27.7K and is scheduled for completion by August 4, 2025. The contract was awarded competitively with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award valued at $11,087.64 from the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, for the supply of Padcev 30mg vials. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,315.70 to AmerisourceBergen Drug Corp for PADCEV 30 mg vials, a pharmaceutical product used in cancer treatment. The contract, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries firm fixed pricing under a non-competitive, non-set-aside delivery order arrangement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,695.90 contract is for the delivery of PADCEV 20 MG VIAL 1S medical supplies. The contract is non-set-aside, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWNEDelivery Order
The Defense Logistics Agency awarded a $14,783.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 20 mg vials of Padcev, a specialized oncology medication. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), is scheduled for completion by October 6, 2025. The pharmaceutical will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, and no set-aside designation was applied to this competitively awarded order. This delivery order exemplifies AmerisourceBergen's critical role as a primary pharmaceutical vendor supporting the Defense Health Agency and broader military healthcare systems. The company maintains a $999,999,999 global pharmaceutical support IDC through December 2026, enabling it to supply an extensive portfolio of brand-name and generic medications, specialty drugs, and medical supplies across multiple therapeutic domains to support military medical operations. The Padcev procurement demonstrates AmerisourceBergen's capability to fulfill specialized pharmaceutical needs as part of the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 9/15/25 |